Skip to main content
. 2020 Sep 9;278(7):2187–2191. doi: 10.1007/s00405-020-06285-0

Fig. 1.

Fig. 1

CT-Scan Finding of COVID-19 anosmic Patients and ACE-2 immunolabelling of olfactory neuroepithelium and middle turbinate. a Sinus CT-Scan showing completely opacified olfactory cleft in COVID-19 anosmic patient; b Using a ACE-2 monoclonal antibody targeting the extracellular part of the receptor, we were able to show that the neuroepithelium (*) expressed a significantly larger amount of ACE-2 compared to middle turbinate (**)